£495.00

The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in China

Price data last checked 58 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 33 days • 33 data points (No recent data available)

Historical
Generating forecast...
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 26 January 2026 03 February 2026 11 February 2026 19 February 2026 27 February 2026

Price Distribution

Price distribution over 33 days • 1 price levels

Days at Price
33 days 0 8 17 25 33 £495 Days at Price

Price Analysis

Most common price: £495 (33 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 33 days

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
24 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in China
97% match

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in China

£495.00 20 Mar 2026
The 2023-2028 Outlook for Enteric Disease Testing-Treatment in China
96% match

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Genetic Modification Therapies in China
96% match

The 2023-2028 Outlook for Genetic Modification Therapies in China

£495.00 09 Jan 2026
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in China
96% match

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in China

£495.00 16 Dec 2025
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China
96% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in China

£495.00 06 Feb 2026
The 2023-2028 Outlook for Amyloidosis Treatments in China
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China

£495.00 20 Jan 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in China
96% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in China

£495.00 13 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in China
96% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in China

£495.00 09 Jan 2026
The 2023-2028 Outlook for Sarcopenia Treatments in China
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in China

£495.00 25 Feb 2026
The 2023-2028 Outlook for Thyroid Gland Disorders Treatments in China
96% match

The 2023-2028 Outlook for Thyroid Gland Disorders Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Erythropoietin Drugs in China
95% match

The 2023-2028 Outlook for Erythropoietin Drugs in China

£495.00 01 Feb 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China
95% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Neglected Tropical Disease Treatments in China
95% match

The 2023-2028 Outlook for Neglected Tropical Disease Treatments in China

£495.00 01 Feb 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China
95% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Alzheimer's Treatments in China
95% match

The 2023-2028 Outlook for Alzheimer's Treatments in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Testosterone Replacement Therapy for Male Hypogonadism in China
95% match

The 2023-2028 Outlook for Testosterone Replacement Therapy for Male Hypogonadism in China

£495.00 13 Jan 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments in China
95% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Hormone Replacement Therapies in China
95% match

The 2023-2028 Outlook for Hormone Replacement Therapies in China

£495.00 09 Jan 2026
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China
95% match

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China

£495.00 10 Mar 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in China
95% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in China

£495.00 13 Dec 2025
The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in China
95% match

The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in China

£495.00 14 Jan 2026
The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in China
95% match

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in China

£495.00 29 Jan 2026
The 2023-2028 Outlook for Hepatorenal Syndrome Treatments in China
95% match

The 2023-2028 Outlook for Hepatorenal Syndrome Treatments in China

£495.00 13 Jan 2026